Vieira Natassia M, Guo Ling T, Estrela Elicia, Kunkel Louis M, Zatz Mayana, Shelton G Diane
The Division of Genetics and Genomics, Boston Children's Hospital, Department of Pediatrics and Genetics, Harvard Medical School, Boston, MA 02115, USA.
Department of Pathology, School of Medicine, University of California San Diego, La Jolla, CA 92093.
Neuromuscul Disord. 2015 May;25(5):363-70. doi: 10.1016/j.nmd.2015.02.012. Epub 2015 Mar 3.
Animal models of dystrophin deficient muscular dystrophy, most notably canine X-linked muscular dystrophy, play an important role in developing new therapies for human Duchenne muscular dystrophy. Although the canine disease is a model of the human disease, the variable severity of clinical presentations in the canine may be problematic for pre-clinical trials, but also informative. Here we describe a family of Labrador Retrievers with three generations of male dogs having markedly increased serum creatine kinase activity, absence of membrane dystrophin, but with undetectable clinical signs of muscle weakness. Clinically normal young male Labrador Retriever puppies were evaluated prior to surgical neuter by screening laboratory blood work, including serum creatine kinase activity. Serum creatine kinase activities were markedly increased in the absence of clinical signs of muscle weakness. Evaluation of muscle biopsies confirmed a dystrophic phenotype with both degeneration and regeneration. Further evaluations by immunofluorescence and western blot analysis confirmed the absence of muscle dystrophin. Although dystrophin was not identified in the muscles, we did not find any detectable deletions or duplications in the dystrophin gene. Sequencing is now ongoing to search for point mutations. Our findings in this family of Labrador Retriever dogs lend support to the hypothesis that, in exceptional situations, muscle with no dystrophin may be functional. Unlocking the secrets that protect these dogs from a severe clinical myopathy is a great challenge which may have important implications for future treatment of human muscular dystrophies.
肌营养不良蛋白缺乏性肌营养不良的动物模型,最显著的是犬X连锁肌营养不良,在开发人类杜氏肌营养不良的新疗法中发挥着重要作用。尽管犬类疾病是人类疾病的模型,但犬类临床表现的严重程度不一,这对临床前试验可能会有问题,但也提供了信息。在此,我们描述了一个拉布拉多猎犬家族,三代雄性犬血清肌酸激酶活性显著增加,缺乏膜肌营养不良蛋白,但无明显的肌肉无力临床症状。在进行手术绝育前,通过筛查实验室血液检查,包括血清肌酸激酶活性,对临床正常的年轻雄性拉布拉多猎犬幼犬进行了评估。在没有肌肉无力临床症状的情况下,血清肌酸激酶活性显著增加。肌肉活检评估证实了具有变性和再生的营养不良表型。通过免疫荧光和蛋白质印迹分析进一步评估证实肌肉中缺乏肌营养不良蛋白。尽管在肌肉中未发现肌营养不良蛋白,但我们在肌营养不良蛋白基因中未发现任何可检测到的缺失或重复。目前正在进行测序以寻找点突变。我们在这个拉布拉多猎犬家族中的发现支持了这样一种假设,即在特殊情况下,没有肌营养不良蛋白的肌肉可能仍具有功能。解开保护这些狗免受严重临床肌病影响的秘密是一项巨大挑战,这可能对未来人类肌营养不良的治疗具有重要意义。